PerpEquities

Stryker Corporation (SYK) income statement

NYSE · Healthcare · Medical - Devices · 56,000 employees · CEO Kevin A. Lobo

Price
$291.86 -6.38%
Market cap
$112B
Enterprise value
$124B
Last report
Q3 '26 filed 2026-10-30
Next report
2027-02-04 EPS est. $5.04

Stryker Corporation (SYK) reported revenue of $6.52B for Q3 '26 (+7.6% year on year), operating income of $1.03B (15.9% of revenue) and net income of $753M. Over the last four quarters revenue was $26.3B.

Income statement

Income statementTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue$5.82B$5.24B$5.42B$5.49B$6.44B$5.87B$6.02B$6.06B$7.17B$6.02B$6.59B$6.52B
Cost of revenue$2.26B$2.05B$2.1B$2.1B$2.45B$2.19B$2.11B$2.21B$2.49B$2.21B$2.09B$2.27B
Gross profit$3.55B$3.19B$3.32B$3.39B$3.99B$3.68B$3.91B$3.85B$4.68B$3.81B$4.5B$4.25B
Research & development$328M$356M$352M$364M$342M$393M$407M$410M$401M$413M$434M$433M
General & administrative$0$0$0$0$0$0$0$0$0$0$2.23B$2.31B
Other operating expenses$0$0$0$0$0$0$392M$262M$88M$180M$176M$468M
Operating expenses$2.13B$2.19B$2.17B$2.19B$2.33B$2.5B$2.8B$2.72B$2.72B$2.87B$2.84B$3.21B
Operating income$1.43B$1B$1.16B$1.21B$1.66B$1.18B$1.11B$1.14B$1.96B$936M$1.66B$1.03B
Interest income$35M$36M$26M$30M$47M$38M$24M$28M$0$0$0$0
Interest expense$0$0$0$0$0$0$159M$157M$381M$148M$141M$0
Other non-operating income (gains on investments, FX ...)$199M$80M$160M$165M$1.14B$415M-$209M$106M$247M-$62M-$46M$37M
Total non-operating income-$199M-$80M-$160M-$165M-$1.14B-$415M-$97M-$106M-$256M-$86M-$95M-$37M
Income before tax$1.23B$923M$998M$1.04B$528M$764M$1.02B$1.03B$1.71B$850M$1.56B$997M
Income tax$83M$135M$173M$209M-$18M$110M$132M$170M$856M$105M$288M$244M
Net income$1.14B$788M$825M$834M$546M$654M$884M$859M$849M$745M$1.28B$753M
EPS (basic)$3.01$2.07$2.17$2.19$1.43$1.71$2.32$2.25$2.21$1.95$3.32$1.97
EPS (diluted)$2.98$2.05$2.14$2.16$1.41$1.69$2.29$2.22$2.20$1.93$3.30$1.96
Shares (basic, weighted)380M380M381M381M381M382M382M382M383M383M384M382M
Shares (diluted, weighted)384M385M385M386M386M386M386M387M387M387M386M385M
Depreciation & amortization$250M$260M$258M$268M$264M$272M$296M$334M$316M$300M$296M$295M
EBITDA$1.48B$1.18B$1.26B$1.31B$792M$1.04B$1.62B$1.36B$2.03B$1.3B$2B$1.29B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Revenue, operating income and growth

quarterly

Margins

quarterly

Costs as % of revenue

quarterly

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-K 2024-12-31, 10-Q 2024-09-30

Not updated in the last refresh (older data or none shown): SEC segments.

Data as of 2026-11-01